Leading Pharmaceutical Biotechnology surged and fell back in early trading, rising nearly 240% at one point during the session

According to BlockBeats, on July 2nd, Hong Kong listed company Leading Pharmaceutical Biotechnology (00399) saw a significant increase in early trading volume, with a rise of nearly 240% at one point. The stock price peaked at HKD 0.7 before falling back to around HKD 0.34. Previously, the company announced plans to acquire all equity in the blockchain project Conflux to expand its presence in the blockchain field. Conflux's two founding members currently serve as its executive directors.